What information is limited regarding perinatal cannabis use?

The correct answer signifies a comprehensive view of the knowledge gaps surrounding perinatal cannabis use, particularly concerning neurodevelopmental effects and teratogenicity. Research on these areas is indeed quite limited, highlighting a need for further investigation into how cannabis use during perinatal periods can affect fetal and infant development.

Neurodevelopmental effects refer to the potential impact that cannabis may have on brain development both during pregnancy and after birth. While some studies suggest risks associated with prenatal cannabis exposure, the extent and specifics of these effects remain inadequately addressed, making it a critical area for ongoing research.

Teratogenicity, which pertains to the potential of a substance to cause developmental malformations in the fetus, also lacks sufficient conclusive data. While some studies have raised concerns, the evidence is not yet robust enough to draw definitive conclusions about the rate and type of malformations linked to cannabis use during pregnancy.

Other options might relate to aspects like breast milk transmission and overall safety during pregnancy. Although these are areas of concern and deserve attention, the knowledge gap regarding both neurodevelopmental effects and teratogenicity most accurately summarizes the current uncertainties. That is why recognizing both as limited in information aligns well with the ongoing dialogue surrounding the implications of cannabis use in perin